|
Volumn 94, Issue 4, 2004, Pages 282-
|
Susceptibility of a series of routine sputum samples for antituberculosis chemotherapy in Gweru, Zimbabwe [9]
a,b c
b
Department of Health
*
(Zimbabwe)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ETHAMBUTOL;
ISONIAZID;
RIFAMPICIN;
RNA POLYMERASE BETA SUBUNIT;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
ACCURACY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIUM CULTURE;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG MONITORING;
FEMALE;
GENE MUTATION;
HEALTH PROGRAM;
HUMAN;
LETTER;
LUNG TUBERCULOSIS;
MAJOR CLINICAL STUDY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
PRACTICE GUIDELINE;
RELAPSE;
SAMPLING;
SPUTUM ANALYSIS;
WORLD HEALTH ORGANIZATION;
ZIMBABWE;
ANTITUBERCULAR AGENTS;
DRUG RESISTANCE, BACTERIAL;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MALE;
MYCOBACTERIUM TUBERCULOSIS;
SPUTUM;
TUBERCULOSIS;
ZIMBABWE;
|
EID: 2342480554
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (4)
|